Table 2.
Demographics and indications of the different HOUSE-classes
| HOUSE 1 | HOUSE 2 | HOUSE 3 | |
|---|---|---|---|
| Gender | |||
| Female (%) | 53.4 | 41.4 | 47.7 |
| Male (%) | 46.6 | 58.6 | 52.3 |
| Agea (year) | 63.8 ± 0.5 | 53.3 ± 0.7 | 55.8 ± 1.2 |
| ASA 1–2 (%) | 64.7 | 58.0 | 67.3 |
| Indications (%) | |||
| Acute pancreatitis | 3.0 | 4.1 | 1.1 |
| Cholangitis | 3.1 | 4.3 | 4.9 |
| Chronic pancreatitis | 1.4 | 9.6 | 10.9 |
| Intraoperative diagnosis | 0.5 | 0.0 | 0.0 |
| Malignancy | 15.0 | 9.6 | 9.0 |
| Obstructive jaundice | 13.9 | 9.4 | 6.0 |
| Other | 7.1 | 16.5 | 31.6 |
| Scheduled control | 11.1 | 15.7 | 4.1 |
| Sec. prophylax biliary pancreatitis | 1.3 | 0.6 | 0.0 |
| Stentdysfunction | 2.8 | 7.0 | 0.8 |
| Susp. bile leakage | 3.8 | 1.9 | 1.5 |
| Susp/known CBDS | 36.0 | 7.2 | 12.8 |
| Susp/known PSC | 0.8 | 14.1 | 17.3 |
aMean ± SEM